Detalhe da pesquisa
1.
Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID-19 vaccine in haemato-oncological patients with no antibody response.
Br J Haematol
; 196(3): 577-584, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34872162
2.
Serological SARS-CoV-2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID-19 vaccine in haematological and oncological patients.
Br J Haematol
; 195(4): 523-531, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34346068
3.
SARS-CoV-2 RBD-specific and NP-specific antibody response of healthcare workers in the westernmost Austrian state Vorarlberg: a prospective cohort study.
BMJ Open
; 12(5): e052130, 2022 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35613821
4.
The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients.
Front Immunol
; 12: 704773, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34220867
5.
Preoperative Assessment of Muscle Mass Using Computerized Tomography Scans to Predict Outcomes Following Orthotopic Liver Transplantation.
Transplantation
; 103(12): 2506-2514, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30985737